Immunomedics (IMMU) Posts Wider-Than-Expected Q1 Loss; Revs Beat
Tweet Send to a FriendGet Alerts IMMU Hot Sheet
Price: $3.06 -2.55%
EPS Growth %: 0.0%
Financial Fact:
Product sales: 751.62K
Today's EPS Names:
RAVN, CAMT, HAST, More
EPS Growth %: 0.0%
Financial Fact:
Product sales: 751.62K
Today's EPS Names:
RAVN, CAMT, HAST, More
Trade IMMU Now!
Immunomedics, Inc. (Nasdaq: IMMU) reports Q1 loss of $0.09, 1 cents worse than the consensus of ($0.08). Revenue for the quarter came in at $1.5 million, compared to the consensus of $1.14 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Alvarion Ltd (ALVR) Narrows Q1 Loss
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
